Synthesis, In Vitro, In Vivo and In Silico Antidiabetic Bioassays of 4-Nitro(thio)phenoxyisobutyric Acids Acting as Unexpected PPARγ Modulators: An In Combo Study
Four isobutyric acids (two nitro and two acetamido derivatives) were prepared in two steps and characterized using spectral analysis. The mRNA concentrations of PPARγ and GLUT-4 (two proteins documented as key diabetes targets) were increased by 3T3-L1 adipocytes treated with compounds <b>1<...
Main Authors: | Blanca Colin-Lozano, Héctor Torres-Gomez, Sergio Hidalgo-Figueroa, Fabiola Chávez-Silva, Samuel Estrada-Soto, Julio Cesar Almanza-Pérez, Gabriel Navarrete-Vazquez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/1/102 |
Similar Items
-
Design, Synthesis and in Combo Antidiabetic Bioevaluation of Multitarget Phenylpropanoic Acids
by: Blanca Colín-Lozano, et al.
Published: (2018-02-01) -
Stereospermum tetragonam as an antidiabetic agent by activating PPARγ and GLUT4
by: Bino Kingsley, et al.
Published: (2014-06-01) -
Insulin Sensitization by PPARγ and GLUT-4 Overexpression/Translocation Mediates the Antidiabetic Effect of <i>Plantago australis</i>
by: Samuel Estrada-Soto, et al.
Published: (2023-04-01) -
PPAR-α Modulators as Current and Potential Cancer Treatments
by: Yan Tan, et al.
Published: (2021-03-01) -
Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation
by: Bodo Haas, et al.
Published: (2024-07-01)